Genetic predisposition to adverse consequences of anti–cholinesterases in ‘atypical’ BCHE carriers

This publication has 21 references indexed in Scilit:

• Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants
  Molecular Brain Research, 1995
• Synaptic and Epidermal Accumulations of Human Acetylcholinesterase Are Encoded by Alternative 3′-Terminal Exons
  Molecular and Cellular Biology, 1995
• Population Diversity and Distinct Haplotype Frequencies Associated with ACHE and BCHE Genes of Israeli Jews from Trans-caucasian Georgia and from Europe
  Genomics, 1994
• Tacrine for Alzheimer's disease. Which patient, what dose?
  JAMA, 1994
• Pyridostigmine used as a nerve agent pretreatment under wartime conditions
  Published by American Medical Association (AMA) ,1991
• Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine
  Pharmacology & Therapeutics, 1990
• Comparison of butyrylcholinesterase and acetylcholinesterase
  Biochemical Journal, 1989
• Acetylcholinesterase from human erythrocyte membranes: dimers as functional units
  FEBS Letters, 1982
• Prediction of drug sensitivity in individuals with atypical serum cholinesterase based on in vitro biochemical studies
  Biochemical Pharmacology, 1981
• The activity of various esterase inhibitors towards atypical human serum cholinesterase
  Biochemical Pharmacology, 1959